- ADVERTISEMENT
-
Most Popular
- ADVERTISEMENT
AMGN
3 Reasons To Be Bullish On Biotech Giant Amgen
The company has had some challenges. But when looking at the long-term, Amgen stock looks like a good play.
This Company is the Landlord of Life Sciences
Alexandria Real Estate Equities is the largest landlord in the US for laboratories and related offices.
This Stock Points to the Massive China Biotech Trend
There is ridiculously big upside potential for Chinese biotech stocks in the next decade. The spread of the pandemic has only strengthened the case.
U.S. Cannabis Stocks Will Make Cheap, Smart Buys in 2020
Matt McCall predicts that 2020 will be a better year for U.S. cannabis stocks. He's also calling for a big rally in bitcoin.
Stock Market Today: New Highs; Buy Micron, Nvidia?
Goldman Sachs analysts came out with three conviction buys on Monday. Here's what else happened in the stock market today.
This $2.7 Billion Deal Is a Shot Across the Bow for Big Pharma
Folks who haven’t been paying attention to the absolutely huge potential happening in biotech stocks right now -- both in the U.S. and other parts of the world -- have been put on notice.
2020 Election Could Hurt Amgen Stock’s Healthy Dividend
The biggest risk to Amgen stock comes from health reform that might limit the number of drugs insurers pay for, creating price competition.
Amgen to Buy Celgene’s Otezla for $13.4B: Is the Deal Good for Amgen Stock?
Amgen's purchase of Celgenes blockbuster psoriasis drug, Otezla is likely to strengthen its position in the immunology space and boost Amgen stock.
Stock Market Today: Biotech in Focus, Trade Talks Steady Stocks
Trade talks gave a lift to stocks, while Johnson & Johnson will be in focus after the close. Here's what happened in the stock market today.